Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
46.09
+0.22 (0.48%)
May 8, 2026, 3:04 PM CST

SHE:300255 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
187.32128236.44230.92797.8543.21
Cash & Short-Term Investments
187.32128236.44230.92797.8543.21
Cash Growth
-33.29%-45.86%2.39%-71.06%46.87%12.93%
Accounts Receivable
306.27251.19265.74238.08452.99317.09
Other Receivables
13.7658.3642.5580.4343.0339.24
Receivables
320.02309.55308.29318.52496.02356.33
Inventory
1,1811,2321,3861,6442,4312,285
Prepaid Expenses
-0.090.08-0.020.29
Other Current Assets
9042.2271.8682.14172.24223.68
Total Current Assets
1,7781,7122,0022,2763,8983,408
Property, Plant & Equipment
1,8031,7901,7131,5911,4831,193
Long-Term Investments
----1.465.8
Goodwill
----1.783.56
Other Intangible Assets
311.05313.57308.13320.55263.82274.06
Long-Term Deferred Tax Assets
17.619.4321.8920.9711.7814
Long-Term Deferred Charges
502.37493.62432.58361.03286.26219.84
Other Long-Term Assets
26.6622.3144.3226.6589.8271.56
Total Assets
4,4394,3514,5234,5966,0365,190
Accounts Payable
399.64434.64307.47263.38249.81106.49
Accrued Expenses
23.4929.4228.1737.4654.2536.57
Short-Term Debt
1,5571,318887.55967.221,0101,272
Current Portion of Long-Term Debt
-540.13873.18586.14351.6134.22
Current Portion of Leases
-80.2856.880.39--
Current Income Taxes Payable
6.070.892.361.143.4523.62
Current Unearned Revenue
9.369.8214.5320.847.4565.86
Other Current Liabilities
401.0570.8132.6544.471.6595.31
Total Current Liabilities
2,3962,4842,2031,9211,7881,734
Long-Term Debt
775.93584.32659.47811.761,129332.47
Long-Term Leases
0.7242.2564.441.26--
Long-Term Unearned Revenue
66.2866.7360.0162.4864.851.02
Long-Term Deferred Tax Liabilities
0.250.260.310.350.190.2
Other Long-Term Liabilities
27.255.27----
Total Liabilities
3,2673,1832,9872,7972,9822,118
Common Stock
919.06919.06919.06919.06934.97934.97
Additional Paid-In Capital
422.74422.74422.74422.74526.84526.84
Retained Earnings
-131.51-137.38220.52469.991,7941,800
Treasury Stock
-----120.01-120.01
Comprehensive Income & Other
-0.14-0.27-0.05-0.13-77.86-73.5
Total Common Equity
1,2101,2041,5621,8123,0583,069
Minority Interest
-38.58-36.08-26.52-11.97-4.023.34
Shareholders' Equity
1,1721,1681,5361,8003,0543,072
Total Liabilities & Equity
4,4394,3514,5234,5966,0365,190
Total Debt
2,3342,5652,5422,3672,4901,739
Net Cash (Debt)
-2,146-2,437-2,305-2,136-1,692-1,195
Net Cash Per Share
-2.34-2.66-2.49-2.32-1.93-1.28
Filing Date Shares Outstanding
919.06919.06919.06919.06919.06919.06
Total Common Shares Outstanding
919.06919.06919.06919.06919.06919.06
Working Capital
-618.56-772.01-200.38354.942,1101,674
Book Value Per Share
1.321.311.701.973.333.34
Tangible Book Value
899.1890.571,2541,4912,7922,791
Tangible Book Value Per Share
0.980.971.361.623.043.04
Buildings
-936.24932.88915.66808.9701.24
Machinery
-538.89538.71545.8389.26339.53
Construction In Progress
-839.2708.97547.74642.27462.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.